P
Patrick Ip
Researcher at University of Hong Kong
Publications - 274
Citations - 6022
Patrick Ip is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 197 publications receiving 3806 citations. Previous affiliations of Patrick Ip include Grantham Hospital & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
Spinal Muscular Atrophy: Survival Pattern and Functional Status
TL;DR: The age of disease onset is defined as the age in which the first abnormalities were obvious from the medical records or from the descriptions of the parents about the first signs of weakness, eg, age of achievement of certain motor milestones or loss of functions.
Journal ArticleDOI
How people react to Zika virus outbreaks on Twitter? A computational content analysis.
TL;DR: Zika-related Twitter incidence peaked after the World Health Organization declared an emergency and user-generated contents sites were preferred direct information channels rather than those of the government authorities.
Journal ArticleDOI
Mercury Exposure in Children With Autistic Spectrum Disorder: Case-Control Study
TL;DR: The results from a cohort study with similar environmental mercury exposure indicate that there is no causal relationship between mercury as an environmental neurotoxin and autism.
Journal ArticleDOI
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
Kenneth K.C. Man,Esther W. Chan,Patrick Ip,David Coghill,David Coghill,Emily Simonoff,Phyllis K L Chan,Wallis C.Y. Lau,Martijn J. Schuemie,Miriam C. J. M. Sturkenboom,Ian C. K. Wong,Ian C. K. Wong +11 more
TL;DR: The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants, and the size of the effect is probably smaller than that reported previously.
Journal ArticleDOI
Association of Risk of Suicide Attempts With Methylphenidate Treatment.
Kenneth K.C. Man,David Coghill,David Coghill,Esther W. Chan,Wallis C.Y. Lau,Chris Hollis,Elizabeth B. Liddle,Tobias Banaschewski,Suzanne McCarthy,Antje Neubert,Kapil Sayal,Patrick Ip,Martijn J. Schuemie,Miriam C. J. M. Sturkenboom,Edmund J.S. Sonuga-Barke,Jan K. Buitelaar,Sara Carucci,Alessandro Zuddas,Hanna Kovshoff,Peter Garas,Peter Nagy,Sarah K. Inglis,Kerstin Konrad,Alexander Häge,Eric Rosenthal,Ian C. K. Wong +25 more
TL;DR: The results do not support a causal association between methylphenidate treatment and suicide attempts, and the observed higher risk of suicide attempts before treatment may reflect emerging psychiatric symptoms that trigger medical consultations that result in a decision to begin ADHD treatment.